Agenda Annual Summit Objectives National Network of Perinatal Quality Collaboratives Annual Summit Thursday, Nov. 29 and Friday, Nov. 30 CDC Roybal Campus 1600 Clifton Road, Atlanta, GA By the end of this meeting, participants will: 1. Describe progress to date towards state s development of a fully functioning PQC 2. List two lessons learned and pitfalls to avoid in state PQC journey to becoming a fully functional PQC 3. Name two practical strategies to accelerate improvement in reducing disparities 4. Describe two ways to engage and learn from family partners in quality improvement Thursday, November 29, 2018 9:00 5:00 pm ET Time Topic & Objectives Speakers Location 8:00 am Registration, Breakfast and Poster Setup 9:00 am Welcome and Introductions Barbara Murphy, MSN, RN Kathleen Rice Simpson, PhD, RNC, FAAN RADM Wanda Barfield, MD, MPH Michael Warren, MD, MPH 9:20 am 9:30 am The Power of PQCs: Our Vision for Improving Perinatal Care Build will to maximize learning from 2-day meeting Prepare to transform perinatal care with successful PQCs A. The New PQC Journey Describe lessons learned from successful PQC experiences State 3 pitfalls to avoid from early PQC efforts Video Remarks: Robert Redfield, MD Elizabeth Coté, MD, MPA Zsakeba Henderson, MD Moderator: William Sappenfield, MD, MPH, CPH Featured PQCs: Charlene Collier, MD, MPH, MHS Mississippi Barbara O Brien, MS, RN Oklahoma
10:30 am Break and Transition to Poster Session 10:40 am B. Poster Session 1 NO CE This poster session will highlight experiences, lessons learned, and successes 11:40 am Lunch and Networking 12:40 pm 1:40 pm Break 1:50 pm 2:40 pm 3:30 pm Break C. Poster Session 2 NO CE This poster session will highlight experiences, lessons learned, and successes D. QI Methodology Understand how common quality improvement models can be applied to state PQCs Explore opportunities for state PQCs to support rigorous use of quality improvement methods by hospital teams Understand how data can be used by state PQCs to support hospital QI efforts E. Health Equity Panel Explain the importance in addressing SDoH in QI efforts to improve perinatal care and outcomes List 3 practical strategies to address and eliminate disparities in perinatal care All teams All teams Angela Anderson CNM, DNP, FACNM Utah Moderator: Munish Gupta, MD, MMSc Featured PQCs: Munish Gupta, MD, MMSc Massachusetts Maya Balakrishnan, MD Florida Ann Borders, MD Illinois Moderator: Joia Crear-Perry, MD, FACOG Panelists: Deidre McDaniel, MSW, LCSW AIM Program Andria Cornell, MPH AMCHP Jochen Profit, MD, MPH Stanford University Hallway Hallway 3:50 pm F. Together is Better: Building National Partnerships List the benefits of collaborating with extended partners in your PQC Moderator: William Sappenfield, MD, MPH, CPH Panelists:
Describe how to engage, recruit and sustain relationships with extended partners 4:50 pm Wrap-up Emma Smizik, MPH 5:00 pm Adjourn Andria Cornell, MPH AMCHP Madge Buus-Frank, DNP, APRN-BC, FAAN VON David Goodman, PhD CDC Jeanne Mahoney, RN, BSN AIM Program Kelly Ernst, MPH March of Dimes
Friday, November 30, 2018 9:00 3:45 pm ET Time Topic Speakers Location 8:00 am Registration and Breakfast 9:00 am Welcome Emma Smizik, MPH Moderator: Lelis Vernon 9:05 am G. Session 4 Family Engagement Panel Plan to apply strategies for authentically engaging families 10:05 am Break & Transition to Breakout Session 1 10:15 am Featured PQCs: Victoria Flanagan, RN, MS Northern New England Marybeth Fry, M.Ed Ohio H. Breakout Session 1: PQC Roles Discuss successes and challenges as they impact team members in their unique roles Elliott Main, MD H1. Data/evaluation managers Linda Detman, PhD Brenda Barker, MBA H2. Program staff Patricia Lee King, PhD, MSW H3. Clinician champions Barbara Murphy, MSN, RN 11:05 am Break & Transition to Breakout Session 2 11:15 am I. Breakout Session 2: PQC Drivers Identify key strategies that will achieve the specific PQC driver aim Develop a testable change to achieve the specific PQC driver aim I1. Primary Driver 1: Engagement and Buy in Carole Lannon, MD, MPH 245 & 246 247 & 248 I2. Primary Driver 2: Launching Initiatives Pooja Mehta, MD, MSHP 245 & 246 I3. Primary Driver 4: Quality Improvement Methods I4. Primary Driver 6: Sustainability 12:05 pm Lunch & Networking Munish Gupta, MD, MMSc 247 Barbara Murphy, MSN, RN Marilyn Kacica, MD, MPH 248
J. Breakout Session 3: Clinical Topics Discuss evidence-based changes and better practices that will improve care for targeted patients and their families J1. Reducing Preterm Birth Jay Iams, MD 245 1:05 pm 1:55 pm Transition 2:05 pm 2:35 pm Break 2:50 pm 3:30 pm 3:45 pm Adjourn J2. Opioid Use Disorder/ Neonatal Abstinence Syndrome J3. Reducing Unnecessary C-sections J4. Neonatal Infection Control/ Antibiotic Stewardship J5. Obstetric Hemorrhage & Hypertension Breakout Session Debrief Report out from breakout discussions with 1-2 practical strategies that other teams could test K. Reactions, Reflections, and Final Sharing Address any remaining questions, concerns, issues Share reflections and any additional strategies not addressed in previous session Closing Remarks/Call to Action Prepare for activities and next steps to accomplish aims Michael Marcotte, MD Michele Walsh, MD Elliott Main, MD William Sappenfield, MD, MPH 246 Marty McCaffrey, MD, CAPT USN 247 Ann Borders, MD Kathryn Menard, MD, MPH Elizabeth Coté, MD, MPA Emma Smizik, MPH Zsakeba Henderson, MD Marybeth Fry, M.Ed Lelis Vernon Zsakeba Henderson, MD 248 ACCREDITATION STATEMENTS: CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and the National Institute for Children s Health Quality. The Centers for Disease Control and Prevention is accredited by the (ACCME ) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Centers for Disease Control and Prevention designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 7.6 contact hours. CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.9 CEU's for this program. CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES ) and/or Master Certified Health Education Specialists (MCHES ) to receive up to 8.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614. For Certified Public Health Professionals (CPH) The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 3 CPH recertification credits for this program. DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use. CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Profit, and he wishes to disclose that he is the Grant Recipient of 3 NIH R01 s and with the exception of Dr. Buus-Frank, and she wishes to disclose that she is the Executive Vice President of Vermont Oxford Network. Planning committee reviewed content to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Iams discussion of progesterone and Dr. Walsh s discussion of opioids. Dr. Iams will be discussing progesterone that may include use of compounded 17-OHPC and vaginal progesterone formulations used off-label both have been the subject of clinical trials and are well known. Dr. Walsh will be discussing opioids for neonatal abstinence syndrome. If CNE Joint Provider: The Centers for Disease Control and Prevention and the National Institute for Children s Health Quality are jointly providing the CNE for this activity. CDC did not accept commercial support for this continuing education activity. In order to receive continuing education (CE) for CM146 please visit TCEO and follow these 9 Simple Steps before 11/29/2020. Complete the Evaluation at www.cdc.gov/getce FEES: There are no fees for CE.